Sign in
8-K

Current Report

ArriVent BioPharma, Inc. Filed Acc 0001104659-26-094869

Material agreement · Results of operations

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.02 Results of operations and financial condition

From the SEC's structured data for this filing

Loading tm2622880d1_8k.htm…